Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06836557
PHASE3

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Sponsor: Vanda Pharmaceuticals

View on ClinicalTrials.gov

Summary

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

Official title: A Multicenter, Open Label, 3-Month Safety Study With Tradipitant in Patients With Idiopathic or Diabetic Gastroparesis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

17

Start Date

2024-01-09

Completion Date

2026-03-30

Last Updated

2026-10-19

Healthy Volunteers

No

Interventions

DRUG

Tradipitant

BID

Locations (3)

Vanda Investigational Site

Leuven, Belgium

Vanda Investigational Site

Liège, Belgium

Vanda Investigational Site

Leipzig, Germany